Header Logo

Connection

Stuart Levitz to Humans

Back to Details
This is a "connection" page, showing publications Stuart Levitz has written about Humans.
Stuart Levitz
Connection Strength
1.103
Humans
  1. Barclay-Korboi YM, Adeel A, Ajami I, Dickson FH, Wachekwa I, Vaye NAF, Levitz SM. Use of sequential lateral flow assays to diagnose cryptococcal infection among people living with HIV in Monrovia, Liberia. PLoS Negl Trop Dis. 2025 Apr; 19(4):e0013008.
    View in: PubMed
    Score: 0.037
  2. Lee CK, Oliveira LVN, Akalin A, Specht CA, Lourenco D, Gomez CL, Ramirez-Ortiz ZG, Wang JP, Levitz SM. Dysregulated pulmonary inflammatory responses exacerbate the outcome of secondary aspergillosis following influenza. mBio. 2023 Oct 31; 14(5):e0163323.
    View in: PubMed
    Score: 0.033
  3. Gandra S, Ram S, Levitz SM. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis. Ann Intern Med. 2021 09; 174(9):1301-1302.
    View in: PubMed
    Score: 0.029
  4. Tomkins-Tinch CH, Daly JS, Gladden-Young A, Theodoropoulos NM, Madaio MP, Yu N, Vanguri VK, Siddle KJ, Adams G, Krasilnikova LA, Movahedi B, Bozorgzadeh A, Simin K, Lemieux JE, Luban J, Park DJ, MacInnis BL, Sabeti PC, Levitz SM. SARS-CoV-2 Reinfection in a Liver Transplant Recipient. Ann Intern Med. 2021 08; 174(8):1178-1180.
    View in: PubMed
    Score: 0.028
  5. Specht CA, Homan EJ, Lee CK, Mou Z, Gomez CL, Hester MM, Abraham A, Rus F, Ostroff GR, Levitz SM. Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles. mBio. 2021 02 22; 13(1):e0336721.
    View in: PubMed
    Score: 0.028
  6. Theodoropoulos NM, Bolstorff B, Bozorgzadeh A, Brandeburg C, Cumming M, Daly JS, Ellison RT, Forsberg K, Gade L, Gibson L, Greenough T, Litvintseva AP, Mack DA, Madoff L, Martins PN, McHale E, Melvin Z, Movahedi B, Stiles T, Vallabhaneni S, Levitz SM. Candida auris outbreak involving liver transplant recipients in a surgical intensive care unit. Am J Transplant. 2020 12; 20(12):3673-3679.
    View in: PubMed
    Score: 0.027
  7. Chang CC, Levitz SM. Fungal immunology in clinical practice: Magical realism or practical reality? Med Mycol. 2019 Jun 01; 57(Supplement_3):S294-S306.
    View in: PubMed
    Score: 0.025
  8. Poowanawittayakom N, Dutta A, Stock S, Touray S, Ellison RT, Levitz SM. Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA. Emerg Infect Dis. 2018 04; 24(4).
    View in: PubMed
    Score: 0.023
  9. Lionakis MS, Levitz SM. Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts. Annu Rev Immunol. 2018 04 26; 36:157-191.
    View in: PubMed
    Score: 0.023
  10. Armstrong-James D, Brown GD, Netea MG, Zelante T, Gresnigt MS, van de Veerdonk FL, Levitz SM. Immunotherapeutic approaches to treatment of fungal diseases. Lancet Infect Dis. 2017 12; 17(12):e393-e402.
    View in: PubMed
    Score: 0.022
  11. Levitz SM. Aspergillus vaccines: Hardly worth studying or worthy of hard study? Med Mycol. 2017 Jan 01; 55(1):103-108.
    View in: PubMed
    Score: 0.021
  12. Loures FV, R?hm M, Lee CK, Santos E, Wang JP, Specht CA, Calich VL, Urban CF, Levitz SM. Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps. PLoS Pathog. 2015 Feb; 11(2):e1004643.
    View in: PubMed
    Score: 0.018
  13. Levitz SM, Huang H, Ostroff GR, Specht CA. Exploiting fungal cell wall components in vaccines. Semin Immunopathol. 2015 Mar; 37(2):199-207.
    View in: PubMed
    Score: 0.018
  14. Santos E, Levitz SM. Fungal vaccines and immunotherapeutics. Cold Spring Harb Perspect Med. 2014 Nov 03; 4(11):a019711.
    View in: PubMed
    Score: 0.018
  15. Bueter CL, Lee CK, Wang JP, Ostroff GR, Specht CA, Levitz SM. Spectrum and mechanisms of inflammasome activation by chitosan. J Immunol. 2014 Jun 15; 192(12):5943-51.
    View in: PubMed
    Score: 0.018
  16. Cole GT, Hung CY, Sanderson SD, Hurtgen BJ, W?thrich M, Klein BS, Deepe GS, Ostroff GR, Levitz SM. Novel strategies to enhance vaccine immunity against coccidioidomycosis. PLoS Pathog. 2013; 9(12):e1003768.
    View in: PubMed
    Score: 0.017
  17. Quintin J, Levitz SM. NKp30 enables NK cells to act naturally with fungi. Cell Host Microbe. 2013 Oct 16; 14(4):369-71.
    View in: PubMed
    Score: 0.017
  18. Bueter CL, Specht CA, Levitz SM. Innate sensing of chitin and chitosan. PLoS Pathog. 2013 Jan; 9(1):e1003080.
    View in: PubMed
    Score: 0.016
  19. Brown GD, Denning DW, Levitz SM. Tackling human fungal infections. Science. 2012 May 11; 336(6082):647.
    View in: PubMed
    Score: 0.015
  20. Levitz SM, Golenbock DT. Beyond empiricism: informing vaccine development through innate immunity research. Cell. 2012 Mar 16; 148(6):1284-92.
    View in: PubMed
    Score: 0.015
  21. Kwon-Chung KJ, Perfect JR, Levitz SM. A chronological history of the International Conference on Cryptococcus and Cryptococcosis (ICCC), an invaluable forum for growth of the cryptococcal research field and clinical practice. Mycopathologia. 2012 Jun; 173(5-6):287-93.
    View in: PubMed
    Score: 0.015
  22. Mansour MK, Vyas JM, Levitz SM. Dynamic virulence: real-time assessment of intracellular pathogenesis links Cryptococcus neoformans phenotype with clinical outcome. mBio. 2011; 2(5).
    View in: PubMed
    Score: 0.015
  23. Agarwal S, Specht CA, Haibin H, Ostroff GR, Ram S, Rice PA, Levitz SM. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. mBio. 2011; 2(5).
    View in: PubMed
    Score: 0.015
  24. Ramirez-Ortiz ZG, Lee CK, Wang JP, Boon L, Specht CA, Levitz SM. A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe. 2011 May 19; 9(5):415-24.
    View in: PubMed
    Score: 0.014
  25. Levitz SM. Innate recognition of fungal cell walls. PLoS Pathog. 2010 Apr 22; 6(4):e1000758.
    View in: PubMed
    Score: 0.013
  26. Levitz SM. Th17 cells bounce off the fungal wall. Cell Host Microbe. 2009 Apr 23; 5(4):311-3.
    View in: PubMed
    Score: 0.012
  27. Huang H, Ostroff GR, Lee CK, Wang JP, Specht CA, Levitz SM. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infect Immun. 2009 May; 77(5):1774-81.
    View in: PubMed
    Score: 0.012
  28. Levitz SM, Shoham S, Cleary JD. Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med. 2009 Feb 05; 360(6):634; author reply 635-6.
    View in: PubMed
    Score: 0.012
  29. Wozniak KL, Levitz SM. Isolation and purification of antigenic components of Cryptococcus. Methods Mol Biol. 2009; 470:71-83.
    View in: PubMed
    Score: 0.012
  30. Wozniak KL, Levitz SM. Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect Immun. 2008 Oct; 76(10):4764-71.
    View in: PubMed
    Score: 0.012
  31. Ramirez-Ortiz ZG, Specht CA, Wang JP, Lee CK, Bartholomeu DC, Gazzinelli RT, Levitz SM. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun. 2008 May; 76(5):2123-9.
    View in: PubMed
    Score: 0.011
  32. Lam JS, Huang H, Levitz SM. Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells. PLoS One. 2007 Oct 10; 2(10):e1009.
    View in: PubMed
    Score: 0.011
  33. Yauch LE, Lam JS, Levitz SM. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2006 Nov; 2(11):e120.
    View in: PubMed
    Score: 0.010
  34. Dan JM, Levitz SM. Prospects for development of vaccines against fungal diseases. Drug Resist Updat. 2006 Jun; 9(3):105-10.
    View in: PubMed
    Score: 0.010
  35. Levitz SM, Boekhout T. Cryptococcus: the once-sleeping giant is fully awake. FEMS Yeast Res. 2006 Jun; 6(4):461-2.
    View in: PubMed
    Score: 0.010
  36. Levitz SM, Specht CA. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res. 2006 Jun; 6(4):513-24.
    View in: PubMed
    Score: 0.010
  37. Mansour MK, Latz E, Levitz SM. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J Immunol. 2006 Mar 01; 176(5):3053-61.
    View in: PubMed
    Score: 0.010
  38. Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol. 2005 Jun; 129(5):569-82.
    View in: PubMed
    Score: 0.009
  39. Kelly RM, Chen J, Yauch LE, Levitz SM. Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect Immun. 2005 Jan; 73(1):592-8.
    View in: PubMed
    Score: 0.009
  40. Mansour MK, Yauch LE, Rottman JB, Levitz SM. Protective efficacy of antigenic fractions in mouse models of cryptococcosis. Infect Immun. 2004 Mar; 72(3):1746-54.
    View in: PubMed
    Score: 0.009
  41. Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem. 2003 Sep 26; 278(39):37561-8.
    View in: PubMed
    Score: 0.008
  42. Sephton-Clark P, McConnell SA, Grossman N, Baker RP, Dragotakes Q, Fan Y, Fu MS, Gerbig G, Greengo S, Hardwick JM, Kulkarni M, Levitz SM, Nosanchuk JD, Shoham S, Smith DFQ, Stempinski P, Timp W, Wear MP, Cuomo CA, Casadevall A. Similar evolutionary trajectories in an environmental Cryptococcus neoformans isolate after human and murine infection. Proc Natl Acad Sci U S A. 2023 01 10; 120(2):e2217111120.
    View in: PubMed
    Score: 0.008
  43. Woodring T, Deepe GS, Levitz SM, Wuethrich M, Klein BS. They shall not grow mold: Soldiers of innate and adaptive immunity to fungi. Semin Immunol. 2023 01; 65:101673.
    View in: PubMed
    Score: 0.008
  44. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem. 2002 Oct 18; 277(42):39320-6.
    View in: PubMed
    Score: 0.008
  45. Mansour MK, Levitz SM. Interactions of fungi with phagocytes. Curr Opin Microbiol. 2002 Aug; 5(4):359-65.
    View in: PubMed
    Score: 0.008
  46. Weber SM, Chen JM, Levitz SM. Inhibition of mitogen-activated protein kinase signaling by chloroquine. J Immunol. 2002 May 15; 168(10):5303-9.
    View in: PubMed
    Score: 0.008
  47. Mansour MK, Schlesinger LS, Levitz SM. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J Immunol. 2002 Mar 15; 168(6):2872-9.
    View in: PubMed
    Score: 0.008
  48. Levitz SM. Receptor-mediated recognition of Cryptococcus neoformans. Nihon Ishinkin Gakkai Zasshi. 2002; 43(3):133-6.
    View in: PubMed
    Score: 0.007
  49. Levitz SM. Does amoeboid reasoning explain the evolution and maintenance of virulence factors in Cryptococcus neoformans? Proc Natl Acad Sci U S A. 2001 Dec 18; 98(26):14760-2.
    View in: PubMed
    Score: 0.007
  50. Levitz SM. Cryptococcus neoformans: intracellular or extracellular? Trends Microbiol. 2001 Sep; 9(9):417-8.
    View in: PubMed
    Score: 0.007
  51. Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol. 2001 Apr 01; 166(7):4620-6.
    View in: PubMed
    Score: 0.007
  52. Hoenigl M, Levitz SM, Schuetz AN, Zhang SX, Cornely OA. All You Need to Know and More about the Diagnosis and Management of Rare Mold Infections. mBio. 2021 02 23; 12(1).
    View in: PubMed
    Score: 0.007
  53. Weber SM, Levitz SM. Chloroquine antagonizes the proinflammatory cytokine response to opportunistic fungi by alkalizing the fungal phagolysosome. J Infect Dis. 2001 Mar 15; 183(6):935-42.
    View in: PubMed
    Score: 0.007
  54. Mambula SS, Simons ER, Hastey R, Selsted ME, Levitz SM. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Infect Immun. 2000 Nov; 68(11):6257-64.
    View in: PubMed
    Score: 0.007
  55. Weber SM, Levitz SM. Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism. J Immunol. 2000 Aug 01; 165(3):1534-40.
    View in: PubMed
    Score: 0.007
  56. Parayath KE, Harrison TS, Levitz SM. Effect of interleukin (IL)-15 priming on IL-12 and interferon-gamma production by pathogen-stimulated peripheral blood mononuclear cells from human immunodeficiency virus-seropositive and -seronegative donors. J Infect Dis. 2000 Feb; 181(2):733-6.
    View in: PubMed
    Score: 0.007
  57. Huang C, Levitz SM. Stimulation of macrophage inflammatory protein-1alpha, macrophage inflammatory protein-1beta, and RANTES by Candida albicans and Cryptococcus neoformans in peripheral blood mononuclear cells from persons with and without human immunodeficiency virus infection. J Infect Dis. 2000 Feb; 181(2):791-4.
    View in: PubMed
    Score: 0.007
  58. Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E, Levitz SM. Cryptococcosis: clinical and biological aspects. Med Mycol. 2000; 38 Suppl 1:205-13.
    View in: PubMed
    Score: 0.006
  59. Lam WC, Upadhya R, Specht CA, Ragsdale AE, Hole CR, Levitz SM, Lodge JK. Chitosan Biosynthesis and Virulence in the Human Fungal Pathogen Cryptococcus gattii. mSphere. 2019 10 09; 4(5).
    View in: PubMed
    Score: 0.006
  60. Abraham A, Ostroff G, Levitz SM, Oyston PCF. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Clin Exp Immunol. 2019 11; 198(2):143-152.
    View in: PubMed
    Score: 0.006
  61. Rongrungruang Y, Levitz SM. Interactions of Penicillium marneffei with human leukocytes in vitro. Infect Immun. 1999 Sep; 67(9):4732-6.
    View in: PubMed
    Score: 0.006
  62. Akilimali NA, Muema DM, Specht C, Chang CC, Moosa MS, Levitz SM, Lewin SR, French MA, Ndung'u T. Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome Is Associated With Dysregulation of IL-7/IL-7 Receptor Signaling Pathway in T Cells and Monocyte Activation. J Acquir Immune Defic Syndr. 2019 04 15; 80(5):596-604.
    View in: PubMed
    Score: 0.006
  63. Levitz SM, Nong SH, Seetoo KF, Harrison TS, Speizer RA, Simons ER. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect Immun. 1999 Feb; 67(2):885-90.
    View in: PubMed
    Score: 0.006
  64. Teitz-Tennenbaum S, Viglianti SP, Roussey JA, Levitz SM, Olszewski MA, Osterholzer JJ. Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection. J Immunol. 2018 10 01; 201(7):2004-2015.
    View in: PubMed
    Score: 0.006
  65. Levitz SM. Host-fungal interactions in HIV infection. Res Immunol. 1998 May-Jun; 149(4-5):489-93; discussion 516-7.
    View in: PubMed
    Score: 0.006
  66. Levitz SM. Improvement in CD4+ cell counts despite persistently detectable HIV load. N Engl J Med. 1998 Apr 09; 338(15):1074-5.
    View in: PubMed
    Score: 0.006
  67. Scriven JE, Tenforde MW, Levitz SM, Jarvis JN. Modulating host immune responses to fight invasive fungal infections. Curr Opin Microbiol. 2017 Dec; 40:95-103.
    View in: PubMed
    Score: 0.006
  68. Levitz SM, Harrison TS, Tabuni A, Liu X. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. J Clin Invest. 1997 Sep 15; 100(6):1640-6.
    View in: PubMed
    Score: 0.006
  69. Harrison TS, Nong S, Levitz SM. Induction of human immunodeficiency virus type 1 expression in monocytic cells by Cryptococcus neoformans and Candida albicans. J Infect Dis. 1997 Aug; 176(2):485-91.
    View in: PubMed
    Score: 0.005
  70. Harrison TS, Levitz SM. Mechanisms of impaired anticryptococcal activity of monocytes from donors infected with human immunodeficiency virus. J Infect Dis. 1997 Aug; 176(2):537-40.
    View in: PubMed
    Score: 0.005
  71. Levitz SM, North EA. Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans. J Med Vet Mycol. 1997 Jul-Aug; 35(4):229-36.
    View in: PubMed
    Score: 0.005
  72. Dambuza IM, Levitz SM, Netea MG, Brown GD. Fungal Recognition and Host Defense Mechanisms. Microbiol Spectr. 2017 07; 5(4).
    View in: PubMed
    Score: 0.005
  73. Levitz SM, North EA, Jiang Y, Nong SH, Kornfeld H, Harrison TS. Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans. Infect Immun. 1997 Mar; 65(3):903-8.
    View in: PubMed
    Score: 0.005
  74. Levitz SM, Tabuni A, Kozel TR, MacGill RS, Ingalls RR, Golenbock DT. Binding of Cryptococcus neoformans to heterologously expressed human complement receptors. Infect Immun. 1997 Mar; 65(3):931-5.
    View in: PubMed
    Score: 0.005
  75. Harrison TS, Levitz SM. Priming with IFN-gamma restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors. J Immunol. 1997 Jan 01; 158(1):459-63.
    View in: PubMed
    Score: 0.005
  76. Jiang Y, Russell TR, Graves DT, Cheng H, Nong SH, Levitz SM. Monocyte chemoattractant protein 1 and interleukin-8 production in mononuclear cells stimulated by oral microorganisms. Infect Immun. 1996 Nov; 64(11):4450-5.
    View in: PubMed
    Score: 0.005
  77. Hogan LH, Klein BS, Levitz SM. Virulence factors of medically important fungi. Clin Microbiol Rev. 1996 Oct; 9(4):469-88.
    View in: PubMed
    Score: 0.005
  78. Harrison TS, Levitz SM. Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. J Immunol. 1996 Jun 01; 156(11):4492-7.
    View in: PubMed
    Score: 0.005
  79. Kozel TR, Tabuni A, Young BJ, Levitz SM. Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells. Infect Immun. 1996 Jun; 64(6):2336-8.
    View in: PubMed
    Score: 0.005
  80. Levitz SM, North EA. gamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans. Infect Immun. 1996 May; 64(5):1595-9.
    View in: PubMed
    Score: 0.005
  81. Levitz SM, Tabuni A, Nong SH, Golenbock DT. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect Immun. 1996 Mar; 64(3):945-51.
    View in: PubMed
    Score: 0.005
  82. Levitz SM, North EA, Dupont MP, Harrison TS. Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes. Infect Immun. 1995 Sep; 63(9):3550-4.
    View in: PubMed
    Score: 0.005
  83. Harrison TS, Kornfeld H, Levitz SM. The effect of infection with human immunodeficiency virus on the anticryptococcal activity of lymphocytes and monocytes. J Infect Dis. 1995 Sep; 172(3):665-71.
    View in: PubMed
    Score: 0.005
  84. Levitz SM, Mathews HL, Murphy JW. Direct antimicrobial activity of T cells. Immunol Today. 1995 Aug; 16(8):387-91.
    View in: PubMed
    Score: 0.005
  85. Panackal AA, Wuest SC, Lin YC, Wu T, Zhang N, Kosa P, Komori M, Blake A, Browne SK, Rosen LB, Hagen F, Meis J, Levitz SM, Quezado M, Hammoud D, Bennett JE, Bielekova B, Williamson PR. Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis. PLoS Pathog. 2015 May; 11(5):e1004884.
    View in: PubMed
    Score: 0.005
  86. Ganesan S, Rathinam VAK, Bossaller L, Army K, Kaiser WJ, Mocarski ES, Dillon CP, Green DR, Mayadas TN, Levitz SM, Hise AG, Silverman N, Fitzgerald KA. Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1? production in response to ?-glucans and the fungal pathogen, Candida albicans. J Immunol. 2014 Sep 01; 193(5):2519-2530.
    View in: PubMed
    Score: 0.004
  87. Levitz SM, Tabuni A, Kornfeld H, Reardon CC, Golenbock DT. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun. 1994 May; 62(5):1975-81.
    View in: PubMed
    Score: 0.004
  88. Brown GD, Meintjes G, Kolls JK, Gray C, Horsnell W, Achan B, Alber G, Aloisi M, Armstrong-James D, Beale M, Bicanic T, Black J, Bohjanen P, Botes A, Boulware DR, Brown G, Bunjun R, Carr W, Casadevall A, Chang C, Chivero E, Corcoran C, Cross A, Dawood H, Day J, De Bernardis F, De Jager V, De Repentigny L, Denning D, Eschke M, Finkelman M, Govender N, Gow N, Graham L, Gryschek R, Hammond-Aryee K, Harrison T, Heard N, Hill M, Hoving JC, Janoff E, Jarvis J, Kayuni S, King K, Kolls J, Kullberg BJ, Lalloo DG, Letang E, Levitz S, Limper A, Longley N, Machiridza TR, Mahabeer Y, Martinsons N, Meiring S, Meya D, Miller R, Molloy S, Morris L, Mukaremera L, Musubire AK, Muzoora C, Nair A, Nakiwala Kimbowa J, Netea M, Nielsen K, O'hern J, Okurut S, Parker A, Patterson T, Pennap G, Perfect J, Prinsloo C, Rhein J, Rolfes MA, Samuel C, Schutz C, Scriven J, Sebolai OM, Sojane K, Sriruttan C, Stead D, Steyn A, Thawer NK, Thienemann F, Von Hohenberg M, Vreulink JM, Wessels J, Wood K, Yang YL. AIDS-related mycoses: the way forward. Trends Microbiol. 2014 Mar; 22(3):107-9.
    View in: PubMed
    Score: 0.004
  89. Levitz SM. Macrophage-Cryptococcus interactions. Immunol Ser. 1994; 60:533-43.
    View in: PubMed
    Score: 0.004
  90. Levitz SM, Dupont MP, Smail EH. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun. 1994 Jan; 62(1):194-202.
    View in: PubMed
    Score: 0.004
  91. Levitz SM, Tabuni A, Treseler C. Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes. Infect Immun. 1993 Nov; 61(11):4891-3.
    View in: PubMed
    Score: 0.004
  92. Roseff SA, Levitz SM. Effect of endothelial cells on phagocyte-mediated anticryptococcal activity. Infect Immun. 1993 Sep; 61(9):3818-24.
    View in: PubMed
    Score: 0.004
  93. Chang CC, Lim A, Omarjee S, Levitz SM, Gosnell BI, Spelman T, Elliott JH, Carr WH, Moosa MY, Ndung'u T, Lewin SR, French MA. Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-? responses before antiretroviral therapy but not higher T-cell responses during therapy. J Infect Dis. 2013 Sep; 208(6):898-906.
    View in: PubMed
    Score: 0.004
  94. Levitz SM, Dupont MP. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. J Clin Invest. 1993 Apr; 91(4):1490-8.
    View in: PubMed
    Score: 0.004
  95. Jarvis JN, Casazza JP, Stone HH, Meintjes G, Lawn SD, Levitz SM, Harrison TS, Koup RA. The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. J Infect Dis. 2013 Jun 15; 207(12):1817-28.
    View in: PubMed
    Score: 0.004
  96. Duncan RA, von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM. Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med. 1993 Feb 11; 328(6):393-8.
    View in: PubMed
    Score: 0.004
  97. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012 Dec 19; 4(165):165rv13.
    View in: PubMed
    Score: 0.004
  98. Cariello PF, Wickes BL, Sutton DA, Castlebury LA, Levitz SM, Finberg RW, Thompson EH, Daly JS. Phomopsis bougainvilleicola prepatellar bursitis in a renal transplant recipient. J Clin Microbiol. 2013 Feb; 51(2):692-5.
    View in: PubMed
    Score: 0.004
  99. Levitz SM, Tabuni A, Wagner R, Kornfeld H, Smail EH. Binding of unopsonized Cryptococcus neoformans by human bronchoalveolar macrophages: inhibition by a large-molecular-size serum component. J Infect Dis. 1992 Oct; 166(4):866-73.
    View in: PubMed
    Score: 0.004
  100. Hurtgen BJ, Hung CY, Ostroff GR, Levitz SM, Cole GT. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis. Infect Immun. 2012 Nov; 80(11):3960-74.
    View in: PubMed
    Score: 0.004
  101. Levitz SM. Overview of host defenses in fungal infections. Clin Infect Dis. 1992 Mar; 14 Suppl 1:S37-42.
    View in: PubMed
    Score: 0.004
  102. McQuillen DP, Zingman BS, Meunier F, Levitz SM. Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis. Clin Infect Dis. 1992 Feb; 14(2):472-8.
    View in: PubMed
    Score: 0.004
  103. Treseler CB, Maziarz RT, Levitz SM. Biological activity of interleukin-2 bound to Candida albicans. Infect Immun. 1992 Jan; 60(1):183-8.
    View in: PubMed
    Score: 0.004
  104. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 1991 Nov-Dec; 13(6):1163-9.
    View in: PubMed
    Score: 0.004
  105. Levitz SM, Diamond RD. Aspergillosis and marijuana. Ann Intern Med. 1991 Oct 01; 115(7):578-9.
    View in: PubMed
    Score: 0.004
  106. Levitz SM. Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans. Infect Immun. 1991 Oct; 59(10):3393-7.
    View in: PubMed
    Score: 0.004
  107. Levitz SM, Farrell TP, Maziarz RT. Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture. J Infect Dis. 1991 May; 163(5):1108-13.
    View in: PubMed
    Score: 0.004
  108. Levitz SM, Tabuni A. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J Clin Invest. 1991 Feb; 87(2):528-35.
    View in: PubMed
    Score: 0.003
  109. Levitz SM, Farrell TP. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infect Immun. 1990 May; 58(5):1201-9.
    View in: PubMed
    Score: 0.003
  110. Levitz SM, Farrell TP. Human neutrophil degranulation stimulated by Aspergillus fumigatus. J Leukoc Biol. 1990 Feb; 47(2):170-5.
    View in: PubMed
    Score: 0.003
  111. Kozel TR, Wilson MA, Farrell TP, Levitz SM. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infect Immun. 1989 Nov; 57(11):3412-7.
    View in: PubMed
    Score: 0.003
  112. Levitz SM. Aspergillosis. Infect Dis Clin North Am. 1989 Mar; 3(1):1-18.
    View in: PubMed
    Score: 0.003
  113. Levitz SM, Tan OT. Factitious dermatosis masquerading as recurrent herpes zoster. Am J Med. 1988 Apr; 84(4):781-3.
    View in: PubMed
    Score: 0.003
  114. Levitz SM, Lyman CA, Murata T, Sullivan JA, Mandell GL, Diamond RD. Cytosolic calcium changes in individual neutrophils stimulated by opsonized and unopsonized Candida albicans hyphae. Infect Immun. 1987 Nov; 55(11):2783-8.
    View in: PubMed
    Score: 0.003
  115. Levitz SM, DiBenedetto DJ, Diamond RD. A rapid fluorescent assay to distinguish attached from phagocytized yeast particles. J Immunol Methods. 1987 Jul 16; 101(1):37-42.
    View in: PubMed
    Score: 0.003
  116. Levitz SM, Diamond RD. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis. 1985 Nov; 152(5):938-45.
    View in: PubMed
    Score: 0.002
  117. Banks IR, Specht CA, Donlin MJ, Gerik KJ, Levitz SM, Lodge JK. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot Cell. 2005 Nov; 4(11):1902-12.
    View in: PubMed
    Score: 0.002
  118. Levitz SM, Diamond RD. Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro. J Infect Dis. 1985 Jul; 152(1):33-42.
    View in: PubMed
    Score: 0.002
  119. Herrero AB, Magnelli P, Mansour MK, Levitz SM, Bussey H, Abeijon C. KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties. Eukaryot Cell. 2004 Dec; 3(6):1423-32.
    View in: PubMed
    Score: 0.002
  120. Levitz SM, Diamond RD. Changing patterns of aspergillosis infections. Adv Intern Med. 1984; 30:153-74.
    View in: PubMed
    Score: 0.002
  121. Kozel TR, Levitz SM, Dromer F, Gates MA, Thorkildson P, Janbon G. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect Immun. 2003 May; 71(5):2868-75.
    View in: PubMed
    Score: 0.002
  122. Ieong MH, Reardon CC, Levitz SM, Kornfeld H. Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity. Am J Respir Crit Care Med. 2000 Sep; 162(3 Pt 1):966-70.
    View in: PubMed
    Score: 0.002
  123. Weber SM, Levitz SM, Harrison TS. Chloroquine and the fungal phagosome. Curr Opin Microbiol. 2000 Aug; 3(4):349-53.
    View in: PubMed
    Score: 0.002
  124. Shafman TD, Levitz S, Nixon AJ, Gibans LA, Nichols KE, Bell DW, Ishioka C, Isselbacher KJ, Gelman R, Garber J, Harris JR, Haber DA. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor. Genes Chromosomes Cancer. 2000 Feb; 27(2):124-9.
    View in: PubMed
    Score: 0.002
  125. Nosanchuk JD, Shoham S, Fries BC, Shapiro DS, Levitz SM, Casadevall A. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med. 2000 Feb 01; 132(3):205-8.
    View in: PubMed
    Score: 0.002
  126. Nichols KE, Levitz S, Shannon KE, Wahrer DC, Bell DW, Chang G, Hegde S, Neuberg D, Shafman T, Tarbell NJ, Mauch P, Ishioka C, Haber DA, Diller L. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease. J Clin Oncol. 1999 Apr; 17(4):1259.
    View in: PubMed
    Score: 0.002
  127. Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, Look AT, Gerald W, Housman DE, Haber DA. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A. 1998 Nov 10; 95(23):13765-70.
    View in: PubMed
    Score: 0.001
  128. Kappe R, Levitz S, Harrison TS, Ruhnke M, Ampel NM, Just-N?bling G. Recent advances in cryptococcosis, candidiasis and coccidioidomycosis complicating HIV infection. Med Mycol. 1998; 36 Suppl 1:207-15.
    View in: PubMed
    Score: 0.001
  129. Meshulam T, Levitz SM, Christin L, Diamond RD. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). J Infect Dis. 1995 Oct; 172(4):1153-6.
    View in: PubMed
    Score: 0.001
  130. Wagner RP, Levitz SM, Tabuni A, Kornfeld H. HIV-1 envelope protein (gp120) inhibits the activity of human bronchoalveolar macrophages against Cryptococcus neoformans. Am Rev Respir Dis. 1992 Dec; 146(6):1434-8.
    View in: PubMed
    Score: 0.001
  131. Kappe R, Levitz SM, Cassone A, Washburn RG. Mechanisms of host defence against fungal infection. J Med Vet Mycol. 1992; 30 Suppl 1:167-77.
    View in: PubMed
    Score: 0.001
  132. Xu T, Levitz SM, Diamond RD, Oppenheim FG. Anticandidal activity of major human salivary histatins. Infect Immun. 1991 Aug; 59(8):2549-54.
    View in: PubMed
    Score: 0.001
  133. Meshulam T, Levitz SM, Diamond RD, Sugar AM. Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils. J Antimicrob Chemother. 1989 Nov; 24(5):741-5.
    View in: PubMed
    Score: 0.001
  134. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem. 1988 Jun 05; 263(16):7472-7.
    View in: PubMed
    Score: 0.001
  135. Brovall C, Levitz SM, Ellner JJ, Schacter B. Radioresistance of culture-induced augmented natural killer-like activity. Hum Immunol. 1983 Jul; 7(3):151-62.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.